Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human

被引:275
作者
Ewart-Toland, A
Briassouli, P
de Koning, JP
Mao, JH
Yuan, JW
Chan, F
MacCarthy-Morrogh, L
Ponder, BAJ
Nagase, H
Burn, J
Ball, S
Almeida, M
Linardopoulos, S [1 ]
Balmain, A
机构
[1] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94115 USA
[2] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England
[3] Inst Canc Res, Haddows Labs, Ctr Canc Therapeut, Canc Res UK, Sutton SM2 5NG, Surrey, England
[4] Strangeways Res Labs, Univ Dept Oncol, Human Canc Genet Grp, Canc Res UK, Cambridge CB1 8RN, England
[5] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[6] Inst Human Genet, Newcastle Upon Tyne NE1 3B2, Tyne & Wear, England
[7] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA
关键词
D O I
10.1038/ng1220
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Linkage analysis and haplotype mapping in interspecific mouse crosses (Mus musculus x Mus spretus) identified the gene encoding Aurora2 (Stk6 in mouse and STK15 in human) as a candidate skin tumor susceptibility gene. The Stk6 allele inherited from the susceptible M. musculus parent was overexpressed in normal cells and preferentially amplified in tumor cells from F 1 hybrid mice. We identified a common genetic variant in STK15 ( resulting in the amino acid substitution F31I) that is preferentially amplified and associated with the degree of aneuploidy in human colon tumors. The Ile31 variant transforms rat1 cells more potently than the more common Phe31 variant. The E2 ubiquitin-conjugating enzyme UBE2N was a preferential binding partner of the weak STK15 Phe31 variant form in yeast two-hybrid screens and in human cells. This interaction results in colocalization of UBE2N with STK15 at the centrosomes during mitosis. These results are consistent with an important role for the Ile31 variant of STK15 in human cancer susceptibility.
引用
收藏
页码:403 / 412
页数:10
相关论文
共 40 条
  • [1] Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene
    Albertson, DG
    Ylstra, B
    Segraves, R
    Collins, C
    Dairkee, SH
    Kowbel, D
    Kuo, WL
    Gray, JW
    Pinkel, D
    [J]. NATURE GENETICS, 2000, 25 (02) : 144 - 146
  • [2] SEQUENTIAL TRISOMIZATION OF CHROMOSOME-6 AND CHROMOSOME-7 IN MOUSE SKIN PREMALIGNANT LESIONS
    ALDAZ, CM
    TRONO, D
    LARCHER, F
    SLAGA, TJ
    CONTI, CJ
    [J]. MOLECULAR CARCINOGENESIS, 1989, 2 (01) : 22 - 26
  • [3] Functional identification of the mouse circadian Clock gene by transgenic BAC rescue
    Antoch, MP
    Song, EJ
    Chang, AM
    Vitaterna, MH
    Zhao, YL
    Wilsbacher, LD
    Sangoram, AM
    King, DP
    Pinto, LH
    Takahashi, JS
    [J]. CELL, 1997, 89 (04) : 655 - 667
  • [4] The genetics and genomics of cancer
    Balmain, A
    Gray, J
    Ponder, B
    [J]. NATURE GENETICS, 2003, 33 (Suppl 3) : 238 - 244
  • [5] Cancer resistance genes in mice: models for the study of tumour modifiers
    Balmain, A
    Nagase, H
    [J]. TRENDS IN GENETICS, 1998, 14 (04) : 139 - 144
  • [6] Evidence for a prostate cancer-susceptibillty locus on chromosome 20
    Berry, R
    Schroeder, JJ
    French, AJ
    McDonnell, SK
    Peterson, BJ
    Cunningham, JM
    Thibodeau, SN
    Schaid, DJ
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (01) : 82 - 91
  • [7] A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers
    Bischoff, JR
    Anderson, L
    Zhu, YF
    Mossie, K
    Ng, L
    Souza, B
    Schryver, B
    Flanagan, P
    Clairvoyant, F
    Ginther, C
    Chan, CSM
    Novotny, M
    Slamon, DJ
    Plowman, GD
    [J]. EMBO JOURNAL, 1998, 17 (11) : 3052 - 3065
  • [8] The Aurora/Ipi1p kinase family: regulators of chromosome segregation and cytokinesis
    Bischoff, JR
    Plowman, GD
    [J]. TRENDS IN CELL BIOLOGY, 1999, 9 (11) : 454 - 459
  • [9] Association study designs for complex diseases
    Cardon, LR
    Bell, JI
    [J]. NATURE REVIEWS GENETICS, 2001, 2 (02) : 91 - 99
  • [10] Positional cloning of ZNF217 and NABC1:: Genes amplified at 20q13.2 and overexpressed in breast carcinoma
    Collins, C
    Rommens, JM
    Kowbel, D
    Godfrey, T
    Tanner, M
    Hwang, S
    Polikoff, D
    Nonet, G
    Cochran, J
    Myambo, K
    Jay, KE
    Froula, J
    Cloutier, T
    Kuo, WL
    Yaswen, P
    Dairkee, S
    Giovanola, J
    Hutchinson, GB
    Isola, J
    Kallioniemi, OP
    Palazzolo, M
    Martin, C
    Ericsson, C
    Pinkel, D
    Albertson, D
    Li, WB
    Gray, JW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) : 8703 - 8708